DeepMed Research

GE MEDICAL SYSTEMS

🇫🇷France

Country: 🇫🇷France

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Clinical Data Collection and Evaluation of ECG-Less Cardiac CT

Completed

Conditions: Cardiac CT

Interventions: Device: ECG-Less Cardiac CT using SmartPhase

First Posted Date: 2023-07-17

Last Posted Date: 2024-06-07

Lead Sponsor: GE Healthcare

Target Recruit Count: 56

Registration Number: NCT05949138

Locations: 🇺🇸
University of Washington, Seattle, Washington, United States
🇺🇸
University of Chicago, Chicago, Illinois, United States

Clinical Data Collection in Breast Tomosynthesis (COBRIS)

Not Applicable

Recruiting

Conditions: Breast Cancer

Interventions: Device: Breast Tomosynthesis

First Posted Date: 2023-06-22

Last Posted Date: 2023-06-22

Lead Sponsor: GE Healthcare

Target Recruit Count: 150

Registration Number: NCT05914168

Locations: 🇫🇷
Gustave Roussy, Villejuif, France

Clinical Feasibility and Evaluation of Silicon Photon Counting CT

Recruiting

Conditions: CT Photon-Counting

Interventions: Device: CT Photon-Counting

First Posted Date: 2023-05-01

Last Posted Date: 2024-06-07

Lead Sponsor: GE Healthcare

Target Recruit Count: 100

Registration Number: NCT05838482

Locations: 🇺🇸
Stanford University, Palo Alto, California, United States

Clinical Data Collection On Advanced CT System

Recruiting

Conditions: CT Photon Counting

Interventions: Device: Investigational Edge-on Silicon Photon Counting CT device

First Posted Date: 2023-04-28

Last Posted Date: 2024-06-07

Lead Sponsor: GE Healthcare

Target Recruit Count: 120

Registration Number: NCT05835284

Locations: 🇸🇪
Karolinska University Hospital, Solna, Sweden

Data Collection for Validation of an NIBP Algorithm in Pregnant Women

Not Applicable

Recruiting

Conditions: Blood Pressure

Interventions: Device: Collecting blood pressure measurements with noninvasive blood pressure device

First Posted Date: 2023-03-29

Last Posted Date: 2023-03-29

Lead Sponsor: GE Healthcare

Target Recruit Count: 170

Registration Number: NCT05789849

Locations: 🇺🇸
Washington University in St. Louis, Saint Louis, Missouri, United States

Altropane Dose for Imaging Patients With Suspected Parkinson's Disease

Phase 2

Terminated

Conditions: Parkinson Disease
Movement Disorders

Interventions: Drug: Altropane (123I) Injection

First Posted Date: 2022-12-05

Last Posted Date: 2024-11-06

Lead Sponsor: GE Healthcare

Target Recruit Count: 15

Registration Number: NCT05636852

Locations: 🇺🇸
Johns Hopkins University, Baltimore, Maryland, United States
🇺🇸
Mayo Clinic, Rochester, Minnesota, United States
🇺🇸
University of Mississippi Medical Center (UMMC), Jackson, Mississippi, United States

and more 1 locations

Study to Evaluate Safety and Dosimetry of [18F]GEH121224 in Patients With Locally Advanced or Metastatic Breast Cancer

Phase 1

Not yet recruiting

Conditions: Breast Cancer

Interventions: Drug: GEH121224 (18F) Injection
Diagnostic Test: Dynamic and Static - PET/CT Scan
Diagnostic Test: Static - PET/CT Scan

First Posted Date: 2022-12-02

Last Posted Date: 2025-02-06

Lead Sponsor: GE Healthcare

Target Recruit Count: 12

Registration Number: NCT05634954

Locations: 🇺🇸
The University of Texas MD Anderson Cancer Centre, Houston, Texas, United States

A Study to Evaluate GEH200520/GEH200521 (18F) Safety and Tolerability When Used for PET Scans in Patients With Solid Tumour Malignancies

Phase 1

Recruiting

Conditions: Oncology
Malignant Solid Tumor

Interventions: Drug: GEH200520 Injection / GEH200521 (18F) Injection - Part A
Drug: GEH200520 Injection / GEH200521 (18F) Injection - Part B
Diagnostic Test: Dynamic and Static - PET/CT scan
Diagnostic Test: Static - PET/CT scan

First Posted Date: 2022-11-29

Last Posted Date: 2025-02-19

Lead Sponsor: GE Healthcare

Target Recruit Count: 50

Registration Number: NCT05629689

Locations: 🇳🇱
UMC Groningen, Groningen, Netherlands

Safety and Pharmacokinetics of GEH200486 in Healthy Volunteers

Phase 1

Completed

Conditions: Pharmacokinetics

Interventions: Drug: GE200486 0.5M Injection

First Posted Date: 2022-10-06

Last Posted Date: 2023-07-06

Lead Sponsor: GE Healthcare

Target Recruit Count: 15

Registration Number: NCT05569278

Locations: 🇳🇴
Rikshospitalet, Oslo, Norway

Impact of 18F-FES PET on the Therapeutic Treatment of Patients With Metastatic Breast Cancer

Phase 4

Active, not recruiting

Conditions: Metastatic Breast Cancer

Interventions: Drug: 18F Fluoroestradiol Radiopharmaceutical with PET/CT

First Posted Date: 2022-08-03

Last Posted Date: 2025-02-12

Lead Sponsor: GE Healthcare

Target Recruit Count: 153

Registration Number: NCT05486182

Locations: 🇫🇷
Institut Curie, Saint-Cloud, France
🇫🇷
Institut Claudius Regaud Centre de Lutte Contre le Cancer, Toulouse, France
🇫🇷
CGFL, Dijon, France

and more 7 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy